Genetic counseling for breast cancer risk: how did we get here and where are we going?

作者: Katherine AF Lang

DOI: 10.1586/14737159.2013.811903

关键词:

摘要: Genetic counselors have been helping patients navigate hereditary cancer risk for decades. The rapidly changing landscape of genetic testing options means the field is again at a unique time in its history. Fears that arose when BRCA first became available are being voiced light next-generation sequencing. origins counseling, best practices, and recommendations come about since those early days need to be well understood before these new challenges can met. role proper assessment preventing adverse outcomes vital as change. In addition, an understanding how various countries incorporated counseling into their healthcare systems provide lessons moving forward capitalizing on technology creating genetics revolution.

参考文章(28)
Ellen T Matloff, Karina L Brierley, Kristen Shannon, Whitney Ducaine, Danielle Campfield, Robin C Schwartz, Lindsay Dohany, Talia Donenberg, Errors in delivery of cancer genetics services: implications for practice. Connecticut medicine. ,vol. 74, pp. 413- 423 ,(2010)
Bettina Meiser, Clara Gaff, Claire Julian-Reynier, Barbara B. Biesecker, Mary Jane Esplen, Andrea Vodermaier, Aad Tibben, International Perspectives on Genetic Counseling and Testing for Breast Cancer Risk Breast Disease. ,vol. 27, pp. 109- 125 ,(2007) , 10.3233/BD-2007-27107
Marc D. Schwartz, Claudine Isaacs, Kristi D. Graves, Elizabeth Poggi, Beth N. Peshkin, Christy Gell, Clinton Finch, Scott Kelly, Kathryn L. Taylor, Lauren Perley, Long‐term outcomes of BRCA1/BRCA2 testing: risk reduction and surveillance Cancer. ,vol. 118, pp. 510- 517 ,(2012) , 10.1002/CNCR.26294
S. M. Domchek, M. M. Gaudet, J. E. Stopfer, M. H. Fleischaut, J. Powers, N. Kauff, K. Offit, K. L. Nathanson, M. Robson, Breast cancer risks in individuals testing negative for a known family mutation in BRCA1 or BRCA2. Breast Cancer Research and Treatment. ,vol. 119, pp. 409- 414 ,(2009) , 10.1007/S10549-009-0611-Y
Janice L. Berliner, Angela Musial Fay, Shelly A. Cummings, Brittany Burnett, Todd Tillmanns, NSGC Practice Guideline: Risk Assessment and Genetic Counseling for Hereditary Breast and Ovarian Cancer Journal of Genetic Counseling. ,vol. 22, pp. 155- 163 ,(2013) , 10.1007/S10897-012-9547-1
Karina L. Brierley, Erica Blouch, Whitney Cogswell, Jeanne P. Homer, Debbie Pencarinha, Christine L. Stanislaw, Ellen T. Matloff, Adverse events in cancer genetic testing: medical, ethical, legal, and financial implications. Cancer Journal. ,vol. 18, pp. 303- 309 ,(2012) , 10.1097/PPO.0B013E3182609490
Bettina Meiser, Phyllis N Butow, Alex L Barratt, Vivienne Schnieden, Michael Gattas, Judy Kirk, Clara Gaff, Graeme Suthers, Kathy Tucker, Familial Cancer Service, J Kirk, M Smith, Hereditary Cancer Clinic, M Clifton, M Friedlander, M Gleeson, V Schnieden, B Thewes, K Tiller, M Tucker, Hunter Genetics, Peter MacCallum Cancer Institute, Queensland Clinical Genetics Services, South Australian Clinical Genetics Services, Victorian Clinical Genetics Services, University of Sydney, Western Australian Clinical Genetics Services, None, Long-term outcomes of genetic counseling in women at increased risk of developing hereditary breast cancer. Patient Education and Counseling. ,vol. 44, pp. 215- 225 ,(2001) , 10.1016/S0738-3991(00)00191-9
Akke Albada, Julie Werrett, Sandra Van Dulmen, Jozien M. Bensing, Cyril Chapman, Margreet G. E. M. Ausems, Alison Metcalfe, Breast cancer genetic counselling referrals: how comparable are the findings between the UK and the Netherlands? Journal of Community Genetics. ,vol. 2, pp. 233- 247 ,(2011) , 10.1007/S12687-011-0061-1